TABLE 1.
Examples of indirect pathogenicity for bacteria that are part of the cystic fibrosis lung microbiome
| Species protected | Protected against | Protected by | Produced by | [Ref.] |
| Haemophilus influenzae | Ampicillin | Penicillinases | Enterobacteriaceae | [39] |
| β-lactam antibiotics | β-lactamases | M. catarrhalis | [40] | |
| Streptococci | Penicillin | Penicillinases | Staphylococci | [41] |
| Ampicillin-susceptible Staphylococcus aureus | Ampicillin | Penicillinases | P. aeruginosa | [42] |
| Streptococcus pneumoniae | β-lactam antibiotics | β-lactamases | M. catarrhalis | [43] |
| Amoxicillin | β-lactamases | H. influenzae | [44] | |
| Chloramphenicol | Chloramphenicol acetyltransferase | Resistant S. aureus/ S. pneumoniae |
[38] | |
| Pseudomonas aeruginosa | Imipenem and ceftazidime | β-lactamases | S. maltophilia | [45] |
| Ceftazidime | β-lactamases | Prevotella sp. | [46] | |
| Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa | Carbapenems | Carbapenem-hydrolysing class D β-lactamases | A. baumannii | [47] |
| Staphylococcus aureus | Gentamicin | Aminoglycoside-modifying enzymes | P. aeruginosa | [48] |